Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.

There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). Here, we augment the proteostasis network of Drosophila SCA3 models with Hsp104, a powerful protein disaggregase...

Full description

Saved in:
Bibliographic Details
Main Authors: Mimi Cushman-Nick, Nancy M Bonini, James Shorter
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Genetics
Online Access:https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1003781&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!